BN-IT963_0609NE_P_20150605142751A story in Tuesday’s edition of the Wall Street Journal highlighted the work of the Pediatric Trials Network to determine the safest, most effective doses and regimens for existing drugs on kids, instead of new uses.  According to the article, this research project, funded by the National Institutes of Health, has involved about 3,500 children in the trials at some 90 locations in the U.S., primarily children’s hospitals.

Read more

How much of a drug is safe for preemies? Via @WSJ: h/t @First_Focus
Tweet this now.

Want to learn more? First Focus is a bipartisan advocacy organization dedicated to making children and families the priority in federal policy and budget decisions. Read more about our work on child health.

Want to get involved? You can support our work on child health by making a donation or joining our mailing list to receive updates and action alerts on these issues.